<code id='3AD44363FB'></code><style id='3AD44363FB'></style>
    • <acronym id='3AD44363FB'></acronym>
      <center id='3AD44363FB'><center id='3AD44363FB'><tfoot id='3AD44363FB'></tfoot></center><abbr id='3AD44363FB'><dir id='3AD44363FB'><tfoot id='3AD44363FB'></tfoot><noframes id='3AD44363FB'>

    • <optgroup id='3AD44363FB'><strike id='3AD44363FB'><sup id='3AD44363FB'></sup></strike><code id='3AD44363FB'></code></optgroup>
        1. <b id='3AD44363FB'><label id='3AD44363FB'><select id='3AD44363FB'><dt id='3AD44363FB'><span id='3AD44363FB'></span></dt></select></label></b><u id='3AD44363FB'></u>
          <i id='3AD44363FB'><strike id='3AD44363FB'><tt id='3AD44363FB'><pre id='3AD44363FB'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:246
          Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

          For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

          When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

          advertisement

          “You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Readout Newsletter: GSK, Viking Therapeutics, mifepristone news
          Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

          SangTan/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewslette

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          CMS should re

          AdobeIn2011,theCentersforMedicareandMedicaidServicescreatedtheannualwellnessvisit(AWV),anewvisittype